Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37302808)

  • 1. WDR54 exerts oncogenic roles in T-cell acute lymphoblastic leukemia.
    Li H; Zhang D; Fu Q; Wang S; Zhang X; Lin Z; Wang Z; Song J; Su Z; Xue V; Liu S; Chen Y; Zhou L; Zhao N; Lu D
    Cancer Sci; 2023 Aug; 114(8):3318-3329. PubMed ID: 37302808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YBX1 as an oncogenic factor in T-cell acute lymphoblastic leukemia.
    Li H; Zhang D; Fu Q; Wang S; Wang Z; Zhang X; Chen X; Zhu X; An N; Chen Y; Zhou L; Lu D; Zhao N
    Blood Adv; 2023 Sep; 7(17):4874-4885. PubMed ID: 37339496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The depletion of Circ-PRKDC enhances autophagy and apoptosis in T-cell acute lymphoblastic leukemia via microRNA-653-5p/Reelin mediation of the PI3K/AKT/mTOR signaling pathway.
    Ling Z; Fang ZG; Wu JY; Liu JJ
    Kaohsiung J Med Sci; 2021 May; 37(5):392-401. PubMed ID: 33615686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sam68 affects cell proliferation and apoptosis of human adult T-acute lymphoblastic leukemia cells via AKT/mTOR signal pathway.
    Wang Q; Li Y; Cheng J; Chen L; Xu H; Li Q; Pang T
    Leuk Res; 2016 Jul; 46():1-9. PubMed ID: 27107742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance and biological function of WD repeat domain 54 as an oncogene in colorectal cancer.
    Yuan Y; Qi G; Shen H; Guo A; Cao F; Zhu Y; Xiao C; Chang W; Zheng S
    Int J Cancer; 2019 Apr; 144(7):1584-1595. PubMed ID: 29987896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrandrine and cepharanthine induce apoptosis through caspase cascade regulation, cell cycle arrest, MAPK activation and PI3K/Akt/mTOR signal modification in glucocorticoid resistant human leukemia Jurkat T cells.
    Xu W; Wang X; Tu Y; Masaki H; Tanaka S; Onda K; Sugiyama K; Yamada H; Hirano T
    Chem Biol Interact; 2019 Sep; 310():108726. PubMed ID: 31255635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CBAP modulates Akt-dependent TSC2 phosphorylation to promote Rheb-mTORC1 signaling and growth of T-cell acute lymphoblastic leukemia.
    Chiang YJ; Liao WT; Ho KC; Wang SH; Chen YG; Ho CL; Huang SF; Shih LY; Yang-Yen HF; Yen JJ
    Oncogene; 2019 Feb; 38(9):1432-1447. PubMed ID: 30266989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol induces apoptosis and autophagy in T-cell acute lymphoblastic leukemia cells by inhibiting Akt/mTOR and activating p38-MAPK.
    Ge J; Liu Y; Li Q; Guo X; Gu L; Ma ZG; Zhu YP
    Biomed Environ Sci; 2013 Nov; 26(11):902-11. PubMed ID: 24331535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin interacts synergistically with idarubicin to induce T-leukemia cell apoptosis in vitro and in a mesenchymal stem cell simulated drug-resistant microenvironment via Akt/mammalian target of rapamycin and extracellular signal-related kinase signaling pathways.
    Wu KN; Zhao YM; He Y; Wang BS; Du KL; Fu S; Hu KM; Zhang LF; Liu LZ; Hu YX; Wang YJ; Huang H
    Leuk Lymphoma; 2014 Mar; 55(3):668-76. PubMed ID: 23741975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Andrographolide inhibits growth of human T-cell acute lymphoblastic leukemia Jurkat cells by downregulation of PI3K/AKT and upregulation of p38 MAPK pathways.
    Yang T; Yao S; Zhang X; Guo Y
    Drug Des Devel Ther; 2016; 10():1389-97. PubMed ID: 27114702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carvedilol exhibits anti-acute T lymphoblastic leukemia effect in vitro and in vivo via inhibiting β-ARs signaling pathway.
    Xu Y; Li J; Luo Y; Ma J; Huang P; Chen Y; He Z
    Biochem Biophys Res Commun; 2023 Jan; 639():150-160. PubMed ID: 36495764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marsdenia tenacissimae extraction (MTE) inhibits the proliferation and induces the apoptosis of human acute T cell leukemia cells through inactivating PI3K/AKT/mTOR signaling pathway via PTEN enhancement.
    Wang Y; Chen B; Wang Z; Zhang W; Hao K; Chen Y; Li K; Wang T; Xie Y; Huang Z; Tong X
    Oncotarget; 2016 Dec; 7(50):82851-82863. PubMed ID: 27756877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of MAML1 inhibits proliferation and induces apoptosis of T-cell acute lymphoblastic leukemia cells through SP1-dependent inactivation of TRIM59.
    Cheng H; Chen L; Hu X; Qiu H; Xu X; Gao L; Tang G; Zhang W; Wang J; Yang J; Huang C
    J Cell Physiol; 2019 Apr; 234(4):5186-5195. PubMed ID: 30370525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oridonin in combination with imatinib exerts synergetic anti-leukemia effect in Ph+ acute lymphoblastic leukemia cells in vitro by inhibiting activation of LYN/mTOR signaling pathway.
    Guo Y; Shan Q; Gong Y; Lin J; Yang X; Zhou R
    Cancer Biol Ther; 2012 Nov; 13(13):1244-54. PubMed ID: 22895079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semaphorin 4D is a potential biomarker in pediatric leukemia and promotes leukemogenesis by activating PI3K/AKT and ERK signaling pathways.
    Jiang H; Tang J; Qiu L; Zhang Z; Shi S; Xue L; Kui L; Huang T; Nan W; Zhou B; Zhao C; Yu M; Sun Q
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LINC00665 promotes the viability, migration and invasion of T cell acute lymphoblastic leukemia cells by targeting miR-101 via modulating PI3K/Akt pathway.
    Abuduer M; A EZG
    Tissue Cell; 2021 Aug; 71():101579. PubMed ID: 34171521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcineurin complex isolated from T-cell acute lymphoblastic leukemia (T-ALL) cells identifies new signaling pathways including mTOR/AKT/S6K whose inhibition synergize with calcineurin inhibition to promote T-ALL cell death.
    Tosello V; Saccomani V; Yu J; Bordin F; Amadori A; Piovan E
    Oncotarget; 2016 Jul; 7(29):45715-45729. PubMed ID: 27304189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting lactate dehydrogenase A (LDHA) exerts antileukemic effects on T-cell acute lymphoblastic leukemia.
    Yu H; Yin Y; Yi Y; Cheng Z; Kuang W; Li R; Zhong H; Cui Y; Yuan L; Gong F; Wang Z; Li H; Peng H; Zhang G
    Cancer Commun (Lond); 2020 Oct; 40(10):501-517. PubMed ID: 32820611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Compound, ND-17, Regulates the JAK/STAT, PI3K/AKT, and MAPK Pathways and Restrains Human T-lymphoid Leukemia Development.
    Ma W; Liu Y; Lei P; Zhu M; Pan X
    Curr Cancer Drug Targets; 2022; 22(5):404-413. PubMed ID: 35249489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wogonoside exerts growth-suppressive effects against T acute lymphoblastic leukemia through the STAT3 pathway.
    Xiao R; Gan M; Jiang T
    Hum Exp Toxicol; 2017 Nov; 36(11):1169-1176. PubMed ID: 27941168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.